Institute of Investigation and Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain;, Richard L. Roudebush VA Medical Center, Indianapolis, Ind., USA;, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China;, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;, Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands;, Departments of Nephrology and Hypertension, Hannover Medical School, Hannover, Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Global Clinical Development, Bayer HealthCare AG, Leverkusen, M.A.R.C.O. GmbH & Co. KG, Düsseldorf, and, Global Research and Development Statistics, Bayer HealthCare AG, Leverkusen, Germany;, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases ‘Aldo e Cele Daccò', Ranica (Bergamo), and, Unit of Nephrology and Dialysis, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy;, Steno Diabetes Center, Gentofte, Denmark;, Global Clinical Development, Bayer S.A., Bayer HealthCare, São Paulo, Brazil;, The University of Chicago Medicine, Chicago, Ill., USA Organization uri icon